Lantu Gou

Dr. Lantu Gou


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2009 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ZLZe-Jun Lu
Ze-Jun Lu
QSQi-Fang Song
Qi-Fang Song
SJSa-Sa Jiang
Sa-Sa Jiang
QSQi Song
Qi Song
WWWei Wang
Wei Wang
YWYu Quan Wei
Yu Quan Wei
Background: Antibody-based immuneotherapy has achieved some success for cancer. But the main problem is that only a few tumor-associated antigens or therapeutic targets have been known to us so far. It is essential to identify more immunogenic antigens (especially cellular membrane markers) for tumor diagnosis and therapy. Methods: The membrane proteins of lung adenocarcinoma cell line A549 were used to immunize the BALB/c mice. A monoclonal antibody 4E7 (McAb4E7) was produced with hybridoma technique. MTT cell proliferation assay was carried out to evaluate the inhibitory effect of McAb4E7 on A549 cells. Flow cytometric assay, immunohistochemistry, western blot and proteomic technologies based on 2-DE and mass spectrometry were employed to detect and identify the corresponding antigen of McAb4E7. Results: The monoclonal antibody 4E7 (McAb4E7) specific against A549 cells was produced, which exhibited inhibitory effect on the proliferation of A549 cells. By the proteomic technologies, we identified that ATP synthase beta subunit (ATPB) was the corresponding antigen of McAb4E7. Then, flow cytometric analysis demonstrated the localization of the targeting antigen of McAb4E7 was on the A549 cells surface. Furthermore, immunohistochemstry showed that the antigen of McAb4E7 mainly aberrantly expressed in tumor cellular membrane in non-small cell lung cancer (NSCLC), but not in small cell lung cancer (SCLC). The rate of ectopic expressed ATPB in the cellular membrane in lung adenocarcinoma, squamous carcinoma and their adjacent nontumourous lung tissues was 71.88%, 66.67% and 25.81% respectively. Conclusion: In the present study, we identified that the ectopic ATPB in tumor cellular membrane was the non-small cell lung cancer (NSCLC) associated antigen. ATPB may be a potential biomarker and therapeutic target for the immunotherapy of NSCLC.

Verified
Journal Article
Open access
PDF file
CSCong-Cong Shen
Cong-Cong Shen
YKYu-Huan Kang
Yu-Huan Kang
MZMing Zhao
Ming Zhao
YHYi He
Yi He
DCDan-Dan Cui
Dan-Dan Cui
LGLantu Gou
Lantu Gou
Treatment for cancer can induce a series of secreted factors into the tumor microenvironment, which can affect cancer progression. Wingless-type MMTV (mouse mammary tumor virus) integration site 16B (WNT16B) is a new member of the WNT family and has been reported to play growth-related roles in previous studies. In this study, we found WNT16B could be expressed and secreted into the microenvironment by human ovarian fibroblasts after DNA damage-associated treatment, including chemotherapy drugs and radiation. We also demonstrated that fibroblast-derived WNT16B could result in accumulation of β-catenin in dendritic cells and secretion of interleukin-10 (IL-10) and transforming growth factor beta (TGF-β), which contributed to the differentiation of regulatory T cells in a co-culture environment. These results shed light on the roles of WNT16B in immune regulation, especially in regard to cancer treatment.

8 April 2011 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
LGLantu Gou
Lantu Gou
WWWei Wang
Wei Wang
ATAiping Tong
Aiping Tong
YYYuqin Yao
Yuqin Yao
YZYan Zhou
Yan Zhou
JYJinliang Yang
Jinliang Yang

8 July 2011 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
YYYuqin Yao
Yuqin Yao
JLJiong Li
Jiong Li
ZLZejun Lu
Zejun Lu
ATAiping Tong
Aiping Tong
WWWei Wang
Wei Wang
YWYuquan Wei
Yuquan Wei

31 March 2011 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
ATAi-Ping Tong
Ai-Ping Tong
WHWen-Jun Huang
Wen-Jun Huang
RZRui Zhou
Rui Zhou
XZXiao-Rong Zeng
Xiao-Rong Zeng
XTXiaoqiu Tan
Xiaoqiu Tan
JYJin-Liang Yang
Jin-Liang Yang
Atrial fibrillation (AF) is the most common form of arrhythmia encountered in clinical practice, and contributes to cardiovascular morbidity and mortality. Despite significant advances in the understanding of the mechanisms associated with AF, the number of effective biomarkers and viable therapeutic targets remains relatively limited. In this study, 2-DE and MS/MS analysis was used to identify differentially expressed proteins in human atrial appendage tissues from patients with AF (n=4) compared to controls with sinus rhythm (SR; n=5). All subjects had rheumatic heart disease. Following 2-DE analysis, Coomassie Brilliant Blue staining and MS/MS identification, a total of 19 protein spots were found to be differentially expressed between the AF and SR groups. By cluster and metabolic/signaling pathway analysis, these proteins were divided into three major groups: proteins involved in the cytoskeleton and myofilament, energy metabolism associated proteins, and proteins associated with oxidative stress. The proteins identified in this study may enable a better understanding of the molecular mechanisms of AF, and may provide useful biomarkers and novel targets for drug development.

12 December 2013 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
PTPing Tang
Ping Tang
LLLi Li
Li Li
YZYan Zhou
Yan Zhou
CSCong‐Cong Shen
Cong‐Cong Shen
YKYu‐Huan Kang
Yu‐Huan Kang
JYJinliang Yang
Jinliang Yang